MASSDEVICE ON CALL — EpiPen providers Pfizer (NYSE:PFE) and Mylan Specialty agreed to a $625,000 settlement to close the books on charges that they misled consumers about the efficacy of the emergency allergy medication dispenser.

The companies in April aired a television commercial, and ran a parallel print ad, that showed a mother and her son discussing the EpiPen system on the way to a birthday party.